[1] |
Ye C, Ruan Y, Zou L, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes [J]. PLoS One, 2014, 9(6): e100180.
|
[2] |
Arulkumaran N, Lightstone L. Severe pre-eclampsia and hypertensive crises [J]. Best Pract Res Clin Obstet Gynaecol, 2013, 27(6): 877-884.
|
[3] |
Schneider S, Freerksen N, Maul H, et al. Risk groups and maternal-neonatal complications of preeclampsia - Current results from the national German Perinatal Quality Registry [J]. J Perinat Med, 2011, 39 (3): 257-265.
|
[4] |
Chaiworapongsa T, Chaemsaithong P, Yeo L, et al. Pre-eclampsia part 1: current understanding of its pathophysiology [J]. Nat Rev Nephrol, 2014, 10(8): 466-480.
|
[5] |
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists′ Task Force on Hypertension in Pregnancy [J]. Obstet Gynecol, 2013, 122(5): 1122-1131.
|
[6] |
Livingston JC, Livingston LW, Ramsey R, et al. Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial [J]. Obstet Gynecol, 2003, 101(2): 217-220.
|
[7] |
Leeman M. Arterial hypertension in pregnancy [J]. Rev Med Brux, 2008, 29(4): 340-345.
|
[8] |
Chaiworapongsa T, Chaemsaithong P, Steven J, et al. Pre-eclampsia part 2: prediction, prevention and management [J]. Nat Rev Nephrol, 2014, 10(9): 531-540.
|
[9] |
Duley L, Henderson-Smart D J. Drugs for treatment of very high blood pressure during pregnancy [J]. Cochrane Database Syst Rev, 2002, 4: CD001449.
|
[10] |
Rosenthal T, Oparil S. The effect of antihypertensive drugs on the fetus [J]. J Hum Hypertens, 2002, 16(5): 293-298.
|
[11] |
Vikse BE, Irgens LM, Leivestad T, et al. Preeclampsia and the risk of end-stage renal disease [J]. N Engl J Med, 2008, 359(8): 800-809.
|
[12] |
Wei Q, Zhang L, Liu X. Outcome of severe preeclampsia manifested as nephrotic syndrome [J]. Arch Gynecol Obstet, 2011, 283(2): 201-204.
|
[13] |
Stratta P, Besso L, Canavese C, et al. Is pregnancy-related acute renal failure a disappearing clinical entity [J]? Renal failure, 1996, 18(4): 575-584.
|
[14] |
Fakhouri F, Vercel C, Frémeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy [J]. Clin J Am Soc Nephrol, 2012, 7(12): 2100-2106.
|
[15] |
Nwoko R, Plecas D, Garovic V D. Acute kidney injury in the pregnant patient [J]. Clin Nephrol, 2012, 78(6): 478-486.
|
[16] |
Prakash J, Niwas SS, Parekh A, et al. Acute kidney injury in late pregnancy in developing countries [J]. Renal failure, 2010, 32(3): 309-313.
|
[17] |
刘力生.中国高血压防治指南2010[J]. 中华高血压杂志,2011, 19(8): 701-708.
|
[18] |
Snydal S. Major changes in diagnosis and management of preeclampsia [J]. J Midwifery Womens Health, 2014, 59(6): 596-605.
|
[19] |
van der Graaf AM, Toering TJ, Faas MM, et al. From preeclampsia to renal disease: a role of angiogenic factors and the renin-angiotensin aldosterone system [J]? Nephrol Dial Transplant, 2012, 27(Suppl 3): iii51-iii57.
|
[20] |
Anderson UD, Olsson MG, Kristensen KH, et al. Review: Biochemical markers to predict preeclampsia [J]. Placenta, 2012, 33(Suppl): S42-S47.
|
[21] |
Hofmeyr GJ, Belizán JM, von Dadelszen P, et al. Low-dose calcium supplementation for preventing preeclampsia: a systematic review and commentary [J]. BJOG, 2014, 121(8): 951-957.
|
[22] |
Poprawski G, Wender-Ozegowska E, Zawiejska A, et al. Modern methods of early screening for preeclampsia and pregnancy-induced hypertension--a review [J]. Ginekol Pol, 2012, 83(9): 688-693.
|